50 /100
MEDIUM RISK
Score updated Jul 14, 2026

GUTS — Fractyl Health, Inc. Dilution Risk Tracker

Track GUTS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GUTS — Get alerts when the score changes →

As of July 14, 2026, Fractyl Health, Inc. (GUTS) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Fractyl Health, Inc. has a market capitalization of $127.90M, 158.65M shares outstanding, 85 institutional holders tracked. Key dilution vectors include approximately 11 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
4
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split 65%
• 50-day avg $0.64 below $1 exchange minimum
• 11 months cash with weak price
🔁 Convertible Conversion 40%
• Significant convertible debt: 21% potential dilution
• Elevated convertible risk (60/100)
💰 Capital Raise 15%
• Under 12 months cash (11mo)
🔔 Track GUTS — Get forecast alerts →

💹 Market Data

Market Cap$127.90M
Shares Outstanding158.65M
Float136.13M
Cash$63.17M
Debt$60.82M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 25.2% shares (2026Q1 vs prior)
85 institutional holders · 86.37M shares
#1 Nantahala Capital Management, LLC 13.36M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 11.07M shares
#3 683 Capital Management, LLC 6.73M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.31M
Days to Cover1.4
% of Float1.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for GUTS Shareholders

Fractyl Health, Inc. (GUTS) has a DilutionScore of 50/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

Cash runway is a key watch item: GUTS has approximately 11 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for GUTS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for GUTS alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track GUTS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GUTS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for GUTS
📊 GUTS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GUTS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.